First Time in Man Trial for Friulimicin B

NCT00492271 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

31

Enrollment

INDUSTRY

Sponsor class

Stopped Unfavourable Pharmakokinetics

Conditions

Community Acquired Pneumonia
Staphylococcal Skin Infections

Interventions

DRUG: Friulimicin B

Sponsor

MerLion Pharmaceuticals GmbH